Anterior Chamber Invasion in Retinoblastoma: Not an Indication for Adjuvant Chemotherapy | Zendy

Kummamuri Sreelakshmi | Zendy; Anita Chandra | Zendy; Subramanian Krishnakumar | Zendy; Viswanathan Natarajan | Zendy; Vikas Khetan | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Anterior Chamber Invasion in Retinoblastoma: Not an Indication for Adjuvant Chemotherapy

Author(s) -

Kummamuri Sreelakshmi,

Anita Chandra,

Subramanian Krishnakumar,

Viswanathan Natarajan,

Vikas Khetan

Publication year - 2017

Publication title -

investigative ophthalmology and visual science

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.935

H-Index - 218

eISSN - 1552-5783

pISSN - 0146-0404

DOI - 10.1167/iovs.17-22111

Subject(s) - retinoblastoma , adjuvant chemotherapy , medicine , adjuvant , chemotherapy , oncology , ophthalmology , biology , cancer , genetics , breast cancer , gene

In retinoblastoma, adjuvant chemotherapy after enucleation is given in eyes with histopathological high-risk features (HRFs) to reduced mortality. Anterior chamber seeds (AC seeds) on histopathological evaluation are a contentious finding. This study attempts to determine the effect of AC seeds on the survival rate.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research